SCHEDULE 13G

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

February 4, 2022

Accession Number

0001908766-22-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →